Upcoming Webinars
How Cancer Drug Prices Affect Access
New cancer treatments can offer meaningful advances—but high prices raise questions about affordability and access.
View detailsPast Webinars
Beyond Measuring Quality of Life in Cancer Trials: Making Results Meaningful for Patients
What do patients want to know about "quality of life"?
View detailsWhen the Cost of Cancer Care Becomes Toxic
The financial burden of cancer care can have profound effects on patients and their families.
View detailsWhat Patients Want from Cancer Drug Approval
How should the FDA balance faster access to new drugs with the need for evidence that they help patients live…
View detailsLeveraging the Midterm Elections to Promote Breast Cancer Priorities
The 2026 midterm elections will have important implications for breast cancer research, access to care, and policies.
View detailsCancer Cells That Survive Treatment: Senescence, Dormancy, and Breast Cancer Recurrence
Why do some cancer cells survive treatment and later contribute to disease recurrence?
View detailsMedicaid Expansion and Breast Cancer Survival
Research shows access to care matters for breast cancer survival.
View detailsWhat Claims Databases Can Tell Us about Real-World Data and Treatment Approaches in Metastatic Breast Cancer
Researchers use real-world data to study treatment patterns, drug sequencing, and biomarker associations.
View detailsMBCACA Campaign Update: Building Momentum for Change
Learn how you can play a role in ending the unnecessary waiting periods for benefits for people with metastatic disease.
View detailsER-Positive Breast Cancer in the Era of Precision Oncology
Hear from experts as they discuss genomics, resistance, and emerging drug targets.
View detailsUrgent Effort to Advance the Metastatic Breast Cancer Access to Care Act
Learn more about the MBCACA and how you can help move it forward.
View detailsCosts and Survival Benefits of Cancer Drugs Approved Through the FDA’s Accelerated Pathway
What does faster approval mean for patients, evidence standards, and health care costs?
View detailsHighlights From 2025 SABCS
Learn about the key clinical trials and research presented at the San Antonio Breast Cancer Symposium.
View detailsRethinking DCIS: What the COMET Trial Means for Patients
Can women with low-risk ductal carcinoma in situ (DCIS) safely avoid aggressive treatment and be monitored with active surveillance?
View detailsDo Patients Gain More Than They Risk in Cancer Trials?
Explore the complex considerations of clinical trial participation and how trials are conceived, evaluated, and experienced.
View detailsHow the Discriminatory Housing Policies of the Past Shape Today’s Breast Cancer Outcomes
Outcomes cannot be fully understood or addressed without grappling with the legacy of structural racism and disinvestment.
View detailsUninformative Clinical Trials: Why They Happen and How Advocates Can Drive Change
Why do too many clinical trials fail to provide meaningful answers that improve patient outcomes?
View detailsHow TRIO-US Is Bringing Cancer Research to Communities
Join this NBCC webinar to hear from experts on TRIO-US’s impact on cutting-edge treatments and its commitment to patient-centered research.
View detailsFinding Clinical Trials that Meet the Needs of Breast Cancer Patients & their Families
Experts share what advocates should know about breast cancer clinical trials and clinical trial diversity.
View details